Results 301 to 310 of about 1,093,427 (365)
Some of the next articles are maybe not open access.

Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial.

The Lancet Oncology, 2021
BACKGROUND Conventional external beam radiotherapy is the standard palliative treatment for spinal metastases; however, complete response rates for pain are as low as 10-20%. Stereotactic body radiotherapy delivers high-dose, ablative radiotherapy.
A. Sahgal   +20 more
semanticscholar   +1 more source

Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial.

The Lancet Oncology, 2021
BACKGROUND Previous phase 2 trials of neoadjuvant anti-PD-1 or anti-PD-L1 monotherapy in patients with early-stage non-small-cell lung cancer have reported major pathological response rates in the range of 15-45%. Evidence suggests that stereotactic body
N. Altorki   +18 more
semanticscholar   +1 more source

Radiotherapy and Radiosurgery

2016
Surgery is the primary treatment modality for patients with craniopharyngiomas. Complete surgical excision is associated with a 5-year tumor growth control of 70–90 % in either adult or pediatric series [1, 2]. For uncompleted resected craniopharyngiomas, local control can be improved with the use of radiotherapy (RT) [3–5]. A few retrospective studies
MINNITI, GIUSEPPE, SCARINGI, CLAUDIA
openaire   +3 more sources

Treatment of a first patient with FLASH-radiotherapy.

Radiotherapy and Oncology, 2019
BACKGROUND When compared to conventional radiotherapy (RT) in pre-clinical studies, FLASH-RT was shown to reproducibly spare normal tissues, while preserving the anti-tumor activity.
J. Bourhis   +11 more
semanticscholar   +1 more source

Radiotherapy

2009
The intrathoracic growth of the tumor causes several severe symptoms as cough, dyspnea, chest pain, hemoptysis, hoarseness, anorexia/nausea, and dysphagia. In patients with manifest or threatening symptoms radiotherapy (RT) as an effective measure should be implemented into the management concept.
openaire   +2 more sources

Radiotherapy of esthesioneuroblastoma

International Journal of Radiation Oncology*Biology*Physics, 2001
Only 3% of all malignant intranasal tumors are esthesioneuroblastomas (ENB). As the tumor is very rare, the number of ENB treated in individual departments is small. In order to evaluate the efficacy of radiotherapy (RT), patients' data of 2 centres were analysed with reference to new reports in literature.From 1981 to 1998, 17 patients with ENB, 8 men
H T, Eich   +5 more
openaire   +2 more sources

Radiotherapy and immunotherapy: a beneficial liaison?

Nature Reviews Clinical Oncology, 2017
Ralph R Weichselbaum   +2 more
exaly   +2 more sources

Nanoparticle‐Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy

Advances in Materials, 2019
External radiotherapy is extensively used in clinic to destruct tumors by locally applied ionizing‐radiation beams. However, the efficacy of radiotherapy is usually limited by tumor hypoxia‐associated radiation resistance.
Qian Chen   +7 more
semanticscholar   +1 more source

Optimization of radiotherapy

International Journal of Radiation Oncology*Biology*Physics, 1979
Abstract Carcinoma of the nasal pharynx, Spinal cord, Optimization of therapy, Treatment characteristic (TC), Radiotherapeutic operating characteristic (ROC).
openaire   +2 more sources

Progress In Radiotherapy

Acta Oncologica, 1995
The 100 years which have elapsed since W.C. Röntgen discovered the x-rays in 1895 have given us a large body of knowledge about the sue of ionizing radiation, and also taught us enough to allow for a statement that there is still much room for improvement.
openaire   +2 more sources

Home - About - Disclaimer - Privacy